fluorodeoxyglucose f18 has been researched along with 2,4-thiazolidinedione in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cendes, F; Cintra, RM; de-Lima-JĂșnior, JC; Folli, F; Monfort-Pires, M; Rachid, B; Ramos, CD; Rodovalho, S; Van de Sande-Lee, S; Velloso, LA | 1 |
1 trial(s) available for fluorodeoxyglucose f18 and 2,4-thiazolidinedione
Article | Year |
---|---|
Effect of pioglitazone treatment on brown adipose tissue volume and activity and hypothalamic gliosis in patients with type 2 diabetes mellitus: a proof-of-concept study.
Topics: Adipose Tissue, Brown; Adult; Aged; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Fluorodeoxyglucose F18; Gliosis; Humans; Hypothalamus; Male; Middle Aged; Obesity; Organ Size; Overweight; Pioglitazone; Positron Emission Tomography Computed Tomography; Proof of Concept Study; Thiazolidinediones | 2019 |